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Introduction
Cryptococcosis is an opportunistic syste-
mic fungal infection and occurs worldwide, 
caused by several Cryptococcus (C.) spe-
cies, which are saprophytic, round, basidi-
omycetous yeasts with C. neoformans 
most commonly causing disease (1, 2, 3). 
Infection occurs in the environment 
through e.g. pigeon droppings and soil rich 
in vegetable matter primarily via inhalation 
through the respiratory system. 
Cryptococcal basidiospores are consid-
ered the main infectious particles due to 
their small size of 2-3 µm, compared to 
vegetative, encapsulated cells (4, 5). In the 
desiccated state, the Cryptococcus organ-
ism may be no larger than 1 µm and may 
survive up to 2 years (2). In infected tissue, 
and often when cultured, the organism is a 
variable-sized yeast (3.5 to 7 µm) with a 
large heteropolysaccharide capsule (1 to 
30 µm) (2). The majority of yeasts settle 
out in the nasal cavity or nasopharynx, 
where they can produce disease or result in 
animals becoming asymptomatic carriers 
of the organism (2).
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Summary 
Disseminated cryptococcosis was diagnosed in 
a cat presenting with severe dyspnoea and 
multiple cutaneous nodules based on cytology, 
serology and culture. A 3.5 years old male, 
castrated, domestic shorthaired cat presented 
with an acute history of progressive dyspnoea, 
tachypnoea and anorexia and a history of chro-
nic continuous stridor, stertor and recurrent 
cutaneous masses.
Nasal and thoracic radiographs showed an 
increased opacity in the nasal cavity, a diffuse 
pulmonary infiltrate and a suspected cranial 
mediastinal mass. Thoracic ultrasound confir-
med the presence of several cranial mediastinal 
masses. Fine needle aspiration of the cutane-
ous and mediastinal masses revealed the pre-
sence of encapsulated yeast cells. Culture con-
firmed infection with Cryptococcus 
neoformans. Latex Cryptococcus agglutination 
antigen test was highly positive with a titer of  
>1:8192. The cat was treated with fluconazole 
for 15 months until the titer was below detec-
table levels. 
Sammendrag 
En kat med svær dyspnø og multiple kutane 
masser blev diagnosticeret med dissemineret 
cryptococcose på basis af cytologiske og 
serologiske undersøgelser samt mykologisk 
dyrkning.
En 3,5 år gammel, kastreret hankat blev 
præsenteret med akut, progressiv dyspnø, 
tachypnø og anorexi. Katten havde haft kro-
nisk stridor og stertor og tilbagevendende 
kutane masser. Røntgenbilleder fra næse og 
thorax viste en øget opklaring i næsehulen, en 
diffus pulmonær infiltrering og en mistænkt 
kranial mediastinal masse. Den sonografiske 
undersøgelse af thorax bekræftede forekom-
sten af flere kraniale mediastinale masser. Fin-
nålsaspiration af de kutane og mediastinale 
masser viste kapseldannende gærceller. Myko-
logisk dyrkning bekræftede infektion med 
Cryptococcus neoformans. Latex Cryptococcus 
Agglutination Antigen Test var kraftigt positiv 
med en titer på >1:8192. Katten blev 
behandlet med fluconazole i 15 måneder indtil 
titeren fandtes negativ.
Dissemination can occur by either direct 
extension or hematogenous spread (by 
macrophages), to the skin, lungs, eyes, or 
central nervous system (CNS) (2, 4, 6). 
Direct extension from the nasal cavity 
through the cribriform plate to the CNS or 
to the paranasal soft tissues and skin is 
common (2). Cell-mediated immune 
response results in granuloma formation 
(2). Direct implantation into skin wounds 
may also occur. Cryptococcosis is a spo-
radic infection, but is considered the most 
common systemic fungal infection in cats 
worldwide (3). Exposure to outdoor envi-
ronments is significantly associated with 
the disease (7, 8, 9). While cryptococcosis 
in people is most often associated with 
immunosuppression, the organism appears 
to be a primary pathogen of immunocom-
petent cats and dogs (2). An association 
with feline leukemia virus (FeLV) and feline 
immunodeficiency virus (FIV) infections in 
cats has been reported, and prolonged 
glucocorticoid treatment has been impli-
cated as a predisposing factor in both cats 
and dogs (2). However, cryptococcosis is 
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not more common in cats with retroviral 
infections (7, 8, 10, 11). Diagnostic 
options of cryptococcosis include cytologic 
examination, capsular antigen detection, 
and culture. Cytological finding in aspi-
rates of encapsulated yeast cells is sugges-
tive. Capsular antigen can be demon-
strated by Latex Cryptococcus 
Agglutination Test (LCAAT) (12). Aetiolog-
ical diagnosis is obtained by culture and 
mycological characterisation of the isolate.
Case History
A 3.5 years old male castrated, domestic 
shorthaired cat presented to the University 
Hospital for Companion Animals at the 
University of Copenhagen with a 5-days 
history of progressing dyspnoea, tachyp-
nea and anorexia. The cat was born and 
raised in California, USA and was imported 
to Denmark one year previously. It had a 
history of long-standing respiratory symp-
toms, described as continuous stridor and 
stertor and occasionally dyspnoea, and 
recurrent cutaneous masses, some of 
which had been surgically removed. There 
was no history of nasal discharge and 
cough was only occasionally observed. The 
cat had been kept indoors for the past 
year, but had been an outdoor cat prior to 
that. It was current on vaccinations, but it 
had not been wormed for the last year. It 
had been treated with amoxicillin/clavula-
nic acid (12.5 mg/kg q12h per os) without 
response for the previous three days. 
Physical examination confirmed tachy-
pnoea (respiratory rate 50 breaths/min-
ute) with an increased inspiratory and 
expiratory effort. Auscultation of the lungs 
was difficult due to pronounced stridor 
and stertor. Mucous membranes were pale 
pink with a capillary refill time of two sec-
onds. The cat had multiple cutaneous, 
indolent, mobile, firm masses of varying 
size with a raised, smooth surface, dis-
persed over the whole body.
The initial therapeutic approach was 
aimed at addressing the respiratory dis-
tress with oxygen supplementation. After 
the initial stabilization, blood was collected 
for complete blood count (CBC), serum 
biochemistry, acid-base chemistry (venous 
blood sample) and Idexx SNAP® FIV/FeLV 
Combo Test. CBC and biochemistry did not 
show any abnormalities except for a mild 
stress-induced hyperglycemia. Acid-base 
chemistry did not show any abnormalities 
either, but as venous blood was used, 
blood oxygenation could not be assessed. 
Lactate was in the reference range. FIV and 
FELV tests were negative. 
Nasal and thoracic radiographs showed 
an increased opacity in the nasal cavity 
and a diffuse pulmonary infiltrate with a 
broncho-interstitial pattern and a sus-
pected cranial mediastinal mass (Figure 1). 
Thoracic ultrasound confirmed the pres-
ence of several cranial mediastinal masses 
(Figure 2). Fine needle aspirates (FNA) of 
all cutaneous masses were performed and 
revealed a yellowish gelatinous content. 
On cytology encapsulated yeast cells were 
observed (Figure 3). 
On day 2, fine needle aspirates of the 
cranial mediastinal masses and a computed 
Figure 3. Cytology from multiple cutaneous lesions 
and mediastinal masses. There is a massive appe-
arance of circular cryptococcal cells of varying size 
surrounded by a large capsule. There is an infiltrate 
of activated highly vacuolized macrophages, sho-
wing active phagocytosis. Background material 
consists of a basophilic lightly granulated material, 
compatible with proteinaceous material. 
Figure 1. Thoracic radiograph of the cat: detail of 
thoracic radiograph, latero-lateral projection. Dif-
fuse pulmonary infiltrate with a broncho-intersti-
tial pattern is visible.
Figure 2. Ultrasonography of the thorax of the cat. 
There are three approximately 1.5 cm in diameter 
roughly spherical masses in the cranial mediasti-
num
tomography (CT) of the nasal cavity and 
thorax were performed under general 
anaesthesia. Recovery from anaesthesia 
was uneventful. In fine needle aspirates of 
the mediastinal masses encapsulated yeast 
cells identical to those from the cutaneous 
masses were demonstrated (Figure 3). 
Computed tomography revealed soft tis-
sue masses in the nasal cavity and frontal 
sinus, nasal turbinate destruction and 
deviation of the nasal septum, soft tissue 
nodules distributed throughout the lungs 
and lung consolidation in the ventral lung 
field (Figure 4).  Aspirated material from a 
cutaneous nodule was cultured on Sab-
ouraud dextrose agar (CM0041, Oxoid, 
Basingstoke, Hampshire, England). After 
incubation at 30° for 7 days, growth was 
observed of grey-white, mucoid colonies 
consisting of budding yeast cells with cap-
sule formation (Figure 5).  A subculture 
was identified as Cryptococcus neoformans 
by using the API 20C AUX kit (BioMerieux, 
3 B: Mediastinal mass.
3 A: Skin. 
>
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Marcy-l’Etoile, France) according to the 
manufacturer’s instructions. Latex Crypto-
coccus agglutination antigen test (LCAAT), 
performed on blood serum at Athens Uni-
versity, Georgia, USA, was highly positive 
with a titer of >1:8192. 
Treatment with the antifungal flucon-
azole (10mg/kg q12h PO) was initiated on 
day 2 based on the cytological findings. 
The cat continued to be stable on cage rest 
and did not require further oxygen supple-
mentation. It was bright, alert and respon-
sive, started eating, and was discharged 
after five days with instructions to ensure a 
quiet, non-stressful environment and 
reduced physical activity. 
Follow-up examinations were performed 
on day 30, 90 and 150. Blood samples for 
biochemistry profile and LCAAT titer were 
obtained to monitor progress of treatment 
and liver parameters, as increased liver 
enzyme activity and hepatic toxicity are 
known as rare side-effects of fluconazole 
treatment. Liver parameters were within 
reference range and LCAAT titers were 
unchanged on all follow-up visits. No clini-
cal side effects to medication were 
observed. On day 30, the cat was bright, 
alert and responsive. The cutaneous nod-
ules were unchanged. On day 90, all nod-
ules had disappeared except for one which 
had decreased in size. On day 150, the last 
nodule had completely disappeared. The 
cat’s activity level had markedly increased 
and the only clinical signs were stridor and 
stertor. Thoracic radiographs were 
obtained which did not show improvement 
compared to previous findings. After mov-
ing back to the USA, LCAAT titer was 
tested 15 months after treatment start 
with levels below detection limit. Flucon-
azole treatment was discontinued. 
Discussion
This presentation of a young cat with 
chronic respiratory symptoms and cutane-
ous nodules due to disseminated crypto-
coccosis represents a rare case in Denmark, 
though the disease is described to have 
worldwide significance. In all likelihood, 
the infection had been acquired during the 
cat’s stay in California, USA, as it had a 
history of long-standing respiratory signs. 
Regarding the cat’s history, systemic 
mycoses were important differential diag-
noses due to a high prevalence in certain 
regions in the USA. All findings including 
the history of long-standing continuous 
upper respiratory tract noise and chronic 
recurrent cutaneous nodules could be 
explained by chronic disseminated crypto-
coccosis with intranasal, intrathoracic and 
cutaneous involvement.
The severe findings on radiography and 
CT indicated irreversible chronic intranasal 
changes and marked pulmonary pathology 
with intrathoracic granulomata which 
might prevent full recovery, so that ongo-
ing respiratory sounds and decreased lung 
capacity would be expected. The presence 
of CNS disease caused by cryptococcosis is 
the major factor described to influence 
outcome in cats (13). In our case, the cat 
did not show any signs of CNS involve-
ment, but as imaging studies of those 
regions were not performed, this could not 
be definitely ruled out. Our patient had a 
LCAAT titer >1:8192 which correlated pos-
itively with the disseminated distribution 
of the disease, as patients with dissemi-
nated skin and/or lymph node involve-
ment have significantly higher titers (12). 
Although the prognosis of cryptococcosis 
should be considered as guarded, a major-
ity of cats can be expected to be cured, 
but treatment is protracted and expensive 
(13). We initiated treatment with flucon-
azole, an azole antifungal, which is 
described to be very effective in the treat-
ment of feline cryptococcosis, including 
cases with advanced, longstanding, or dis-
seminated disease (2, 13, 14). Further-
more, this drug can be given orally. Side 
effects in cats can be inappetence and, 
rarely, increased liver enzyme activity and 
hepatic toxicity (14). On follow-up visits, 
liver enzyme activity and LCAAT titers were 
measured to monitor progress, evaluate 
prognosis, and guide cessation of treat-
ment (2, 12, 15, 16). The cat responded 
well to treatment and no side effects were 
observed. Antifungal therapy was contin-
ued until the LCAAT titer declined to an 
undetectable level after 15 months of con-
tinued therapy. This was a significantly 
longer treatment period than described in 
a previous study where the median dura-
tion of treatment with fluconazole in cats 
Figure 4. CT nasal cavity and thorax (2 mm slice thickness). A: Nasal cavity: soft tissue filling bilaterally in 
the nasal cavity and in the left frontal sinus, bilateral nasal turbinate destruction and deviation of the 
nasal septum. B: Thorax: soft tissues nodules distributed throughout the lungs and significant consolida-
tion of the lungs in the ventral lung field. 
Figure 5. Culture on Sabouraud dextrose agar of 
isolate from aspirated material from a cutaneous 
nodule, incubated at for 30°C for 6 days, showing 
mucoid, grey-white colonies.
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with less severe cryptococcosis was 4 
months with a range of 1 to 8 months (13). 
Due to the advanced disease progression 
in our patient, a longer treatment period 
was expected. Despite clinical improve-
ment, resolution of the cutaneous masses 
and a finally undetectable LCAAT titer, a 
full recovery with resolution of all respira-
tory symptoms seems unlikely due to the 
severe intranasal anatomical changes.
 This case report emphasises that it is 
important to consider cryptococcosis in 
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